TY  - GEN
AU  - De Groot,S
AU  - Blommestein,H M
AU  - Redekop,W K
AU  - Sleijfer,S
AU  - Kiemeney,L A L M
AU  - Oosterwijk,E
AU  - Uyl-de Groot,C A
TI  - Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments
SN  - 1932-6203
PY  - 2017///0914
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - economics
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Cost of Illness
KW  - Cost-Benefit Analysis
KW  - Female
KW  - Humans
KW  - Indoles
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Netherlands
KW  - Pyrroles
KW  - Quality-Adjusted Life Years
KW  - Registries
KW  - Regression Analysis
KW  - Sunitinib
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1371/journal.pone.0177364
ER  -